Kala Bio Transitions to Revenue Model with AI

Penny stock company Kala Bio is shifting its business model towards revenue generation with the launch of its BIRA AI platform. This new AI agent is designed to support biotech research, marking a significant transition from development to commercial deployment. The move signifies Kala Bio's strategic pivot to establish a recurring revenue stream, leveraging artificial intelligence to drive its future growth and market position in the competitive biotech landscape.